高级检索
当前位置: 首页 > 详情页

Type I coil gen promotes tumor progression of integrin 131 positive gastric cancer tnrough a BCL9/beta-catenin signaling pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

机构: [1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China [2]Cangzhou Cent Hosp, Dept Oncol, Cangzhou, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Dept Immunol & Rheumatol, Shijiazhuang, Hebei, Peoples R China [4]Lifehealthcare Clin Labs, Hangzhou, Zhejiang, Peoples R China
出处:
ISSN:

关键词: type I collagen integrin beta 1 BCL9L beta-catenin gastric cancer

摘要:
The mechanism of extracellular matrix induced tumor progression is poorly understood. Based on the TCGA database and clinical tumor tissues analysis, we observed abundant type I collagen expression in tumor tissues and poor overall survival in gastric patients with high integrin 131 (ITGB1) expression. In vitro, our study found that 3D collagen culture promoted the capability of colony formation and growth in ITGB1 positive gastric cancer, whereas limited colony growth was observed in ITGB1 negative gastric cancer, suggesting the role of ITGB1 in type I collagen associated tumor progression. Mechanistically, we demonstrated that type I collagen was capable of promoting the activation of BCL9L/beta-catenin signaling pathway through ITGB1, thereby contributing to the gastric cancer development. Subsequently, beta-catenin signals further up-regulated the expression anti-apoptosis protein BCL2, leading to the chemo-resistance in gastric cancer cells. Blockade of 13-catenin signals efficiently improved the anticancer effects of chemotherapy, providing an innovative sight for clinical gastric cancer therapy.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 老年医学 3 区 细胞生物学
最新[2025]版:
JCR分区:
出版当年[2021]版:
Q2 CELL BIOLOGY Q2 GERIATRICS & GERONTOLOGY
最新[2023]版:
Q2 CELL BIOLOGY Q2 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Med Oncol, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Dept Immunol & Rheumatol, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号